MARKET

RFL

RFL

Rafael Holdings
NYSE
1.720
0.000
0.00%
Closed 16:00 03/28 EDT
OPEN
1.710
PREV CLOSE
1.720
HIGH
1.750
LOW
1.710
VOLUME
11.74K
TURNOVER
0
52 WEEK HIGH
2.520
52 WEEK LOW
1.440
MARKET CAP
42.29M
P/E (TTM)
20.43
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at RFL last week (0318-0322)?
Weekly Report · 3d ago
Solid Earnings May Not Tell The Whole Story For Rafael Holdings (NYSE:RFL)
Rafael Holdings, Inc.'s profit received a boost of US$10.0m in unusual items, over the last year. The company earned a profit in the last twelve months, despite its previous loss. Rafael Holdings' statutory profits may be a bad guide to its underlying earnings power.
Simply Wall St · 03/21 11:26
Weekly Report: what happened at RFL last week (0311-0315)?
Weekly Report · 03/18 09:06
Rafael Holdings reports Q2 results
Seeking Alpha · 03/14 15:03
Press Release: Rafael Holdings Reports Second -2-
The company has a total of 3,895,000 shares of common stock. The company's common stock is traded on the New York Stock Exchange. The Company has no debt and no liabilities. The company has no current or future liabilities. The stock price of the common stock of the company has risen to $3.75 per share.
Dow Jones · 03/13 21:04
Press Release: Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a majority interest of 79% for the second quarter of fiscal 2024 -- and the six months ended January 31, 2024.
Dow Jones · 03/13 21:04
Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
Barchart · 03/13 16:04
Weekly Report: what happened at RFL last week (0304-0308)?
Weekly Report · 03/11 09:06
More
About RFL
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.

Webull offers Rafael Holdings Inc stock information, including NYSE: RFL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RFL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RFL stock methods without spending real money on the virtual paper trading platform.